• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2010 年胆汁淤积性肝病的遗传学研究进展。

Genetics of cholestatic liver disease in 2010.

机构信息

Norwegian PSC Research Center, Medical Department, Oslo University Hospital Rikshospitalet, Oslo, Norway.

出版信息

Curr Opin Gastroenterol. 2010 May;26(3):251-8. doi: 10.1097/MOG.0b013e328336807d.

DOI:10.1097/MOG.0b013e328336807d
PMID:20042859
Abstract

PURPOSE OF REVIEW

Many of the cholestatic diseases show similar clinical features, despite underlying differences in the genetic etiology. The present review aims to present recent insight into this etiological heterogeneity.

RECENT FINDINGS

Mutations in the genes causing progressive familial intrahepatic cholestasis are also involved in less severe phenotypes like benign recurrent intrahepatic cholestasis, gallstone disease, intrahepatic cholestasis of pregnancy and drug-induced cholestasis. This probably represents a continuum of severity of the mutations involved, but also complex patterns of inheritance ranging from monogenic autosomal recessive disorders to heterozygosity only conferring a moderate increase in disease risk, where additional genetic or environmental factors are needed to acquire a disease phenotype. Recent genome-wide association studies in the inflammatory cholestatic diseases primary biliary cirrhosis and primary sclerosing cholangitis have revealed susceptibility genes involved in autoimmunity and inflammatory bowel disease, whereas the genetic risk factors for the biliary preference of these diseases remain unknown.

SUMMARY

The complexity of the genetic contribution to cholestatic liver disease needs to be accounted for to fully understand the pathogenesis of these conditions.

摘要

目的综述

尽管在遗传病因学上存在差异,但许多胆汁淤积性疾病表现出相似的临床特征。本综述旨在介绍该病因异质性的最新见解。

最近的发现

导致进行性家族性肝内胆汁淤积症的基因突变也与较轻的表型有关,如良性复发性肝内胆汁淤积症、胆石症、妊娠肝内胆汁淤积症和药物性胆汁淤积症。这可能代表了所涉及突变严重程度的连续体,也代表了从单基因常染色体隐性疾病到仅杂合性赋予疾病风险中度增加的复杂遗传模式,其中需要额外的遗传或环境因素才能获得疾病表型。最近在炎症性胆汁淤积性疾病原发性胆汁性胆管炎和原发性硬化性胆管炎中的全基因组关联研究揭示了自身免疫和炎症性肠病相关的易感性基因,而这些疾病对胆管的遗传风险因素仍不清楚。

总结

遗传因素对胆汁淤积性肝病的复杂性需要加以考虑,以充分了解这些疾病的发病机制。

相似文献

1
Genetics of cholestatic liver disease in 2010.2010 年胆汁淤积性肝病的遗传学研究进展。
Curr Opin Gastroenterol. 2010 May;26(3):251-8. doi: 10.1097/MOG.0b013e328336807d.
2
Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders.胆汁淤积性肝病:在理解和治疗缓慢进展性疾病方面进展缓慢。
Scand J Gastroenterol Suppl. 2000(232):86-92.
3
FIC1 disease: a spectrum of intrahepatic cholestatic disorders.FIC1病:一系列肝内胆汁淤积性疾病。
Semin Liver Dis. 2001 Nov;21(4):535-44. doi: 10.1055/s-2001-19034.
4
Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations.妊娠期肝内胆汁淤积症:三种新的多药耐药蛋白3(MDR3)基因突变
Aliment Pharmacol Ther. 2006 Jun 1;23(11):1649-53. doi: 10.1111/j.1365-2036.2006.02869.x.
5
Progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症
Acta Biomed. 2002;73(3-4):53-6.
6
[Benign recurring intrahepatic cholestasis--a case report].[良性复发性肝内胆汁淤积——一例报告]
Z Gastroenterol. 1984 Jun;22(6):300-4.
7
Familial intrahepatic cholestatic syndromes.家族性肝内胆汁淤积综合征
Semin Liver Dis. 1987 May;7(2):119-33. doi: 10.1055/s-2008-1040571.
8
Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy.ATP8B1基因序列变异与妊娠期肝内胆汁淤积症
Eur J Hum Genet. 2005 Apr;13(4):435-9. doi: 10.1038/sj.ejhg.5201355.
9
ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.成年胆汁淤积性肝病患者的ABCB4基因突变:影响及表型表达
J Gastroenterol. 2016 Mar;51(3):271-80. doi: 10.1007/s00535-015-1110-z. Epub 2015 Sep 1.
10
The influence of common gene variants of the xenobiotic receptor (PXR) in genetic susceptibility to intrahepatic cholestasis of pregnancy.常见外源物质受体(PXR)基因变异对妊娠肝内胆汁淤积症遗传易感性的影响。
Aliment Pharmacol Ther. 2010 Mar;31(5):583-92. doi: 10.1111/j.1365-2036.2009.04210.x. Epub 2009 Dec 3.

引用本文的文献

1
Cystic fibrosis related liver disease--another black box in hepatology.囊性纤维化相关肝病——肝病学中的另一个未知领域。
Int J Mol Sci. 2014 Aug 4;15(8):13529-49. doi: 10.3390/ijms150813529.
2
Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease.无炎症性肠病的小胆管原发性硬化性胆管炎在基因上与大胆管疾病不同。
Liver Int. 2014 Nov;34(10):1488-95. doi: 10.1111/liv.12492. Epub 2014 Mar 7.
3
Description of two new ABCB11 mutations responsible for type 2 benign recurrent intrahepatic cholestasis in a French-Canadian family.
法裔加拿大人家族中导致2型良性复发性肝内胆汁淤积症的两个新ABCB11突变的描述。
Can J Gastroenterol. 2011 Jun;25(6):311-4. doi: 10.1155/2011/534918.
4
Impaired fetal adrenal function in intrahepatic cholestasis of pregnancy.妊娠肝内胆汁淤积症胎儿肾上腺功能受损。
Med Sci Monit. 2011 May;17(5):CR265-71. doi: 10.12659/msm.881766.
5
Cutting-edge issues in primary biliary cirrhosis.原发性胆汁性肝硬化的前沿问题。
Clin Rev Allergy Immunol. 2012 Jun;42(3):342-54. doi: 10.1007/s12016-011-8253-3.
6
Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis.原发性硬化性胆管炎中胆汁酸受体 TGR5 的突变特征。
PLoS One. 2010 Aug 25;5(8):e12403. doi: 10.1371/journal.pone.0012403.